Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / SHS NEW
-
Total 13F shares
-
1,411,575
-
Share change
-
-18,833
-
Total reported value
-
$7,567,157
-
Put/Call ratio
-
250%
-
Price per share
-
$5.35
-
Number of holders
-
10
-
Value change
-
-$131,117
-
Number of buys
-
6
-
Number of sells
-
6
Institutional Holders of CollPlant Biotechnologies Ltd - SHS NEW (CLGN) as of Q1 2024
As of 31 Mar 2024,
CollPlant Biotechnologies Ltd - SHS NEW (CLGN) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,411,575 shares.
The largest 10 holders included
PINNACLE ASSOCIATES LTD, VILLERE ST DENIS J & CO LLC, Roumell Asset Management, LLC, BROWN ADVISORY INC, BENJAMIN F. EDWARDS & COMPANY, INC., CITADEL ADVISORS LLC, BANK OF AMERICA CORP /DE/, UBS Group AG, PNC Financial Services Group, Inc., and Qube Research & Technologies Ltd.
This page lists
10
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.